Vamorolone
- Part D specialty tier in 63% of formularies (2026Q3)
- AGAMREE
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Vamorolone: storage and handling
- Refrigerate
- Yes, as the label states
Label statement
After opening, store the bottle upright in a refrigerator 2°C to 8°C (36°F to 46°F).
- Freezing
- Do not freeze
Label statement
Do not freeze.
- Room temperature
- at or below 25°C (77°F)
Label statement
Store the bottle upright at room temperature between 20°C to 25°C (68°F to 77°F).
- Room temperature
- at or below 25°C (77°F)
Label statement
Storing AGAMREE Store the unopened bottle upright at room temperature between 68°F to 77°F (20°C to 25°C) in the original carton.
- Back into the refrigerator
- Not addressed
- Light
- Not addressed
- Shaking
- Not addressed
All storage statements on the label (10)
- Store the bottle upright at room temperature between 20°C to 25°C (68°F to 77°F).
- Excursions permitted between 15°C to 30°C (59°F to 86°F) in the original carton.
- See USP controlled room temperature.
- After opening, store the bottle upright in a refrigerator 2°C to 8°C (36°F to 46°F).
- Do not freeze.
- Discard any unused AGAMREE oral suspension remaining after 3 months of first opening the bottle.
- Storing AGAMREE Store the unopened bottle upright at room temperature between 68°F to 77°F (20°C to 25°C) in the original carton.
- After opening the bottle, store the bottle upright in a refrigerator between 36°F to 46°F (2°C to 8°C).
- Throw away (discard) any unused AGAMREE oral suspension remaining after 3 months of first opening the bottle.
- Make sure the child-resistant bottle cap is tightly secured and shake the bottle well for about 30 seconds.
FDA label version 10, effective January 22, 2026. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.